Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) is simply too cheap to pass with a price-to-sales ratio of 4.32. The competitors from Biotechnology hold an average P/S ratio of 8.69, which offer discount compared with the sector’s 10.47. In the past 13-year record, this ratio went down as low as 0.79 and as high as 2640. Also, it is down from 57.% of the total 726 rivals across the globe.
TTNP traded at an unexpectedly low level on 03/12/2019 when the stock experienced a -0.55% loss to a closing price of $1.8. The company saw 0.28 million shares trade hands over the course of the day. Given that its average daily volume over the 5 sessions has been 1.24 million shares a day, this signifies a pretty significant change over the norm.
Titan Pharmaceuticals, Inc. (TTNP) Analyst Gushes
Analysts are speculating a 116.67% move, based on the high target price ($3.9) for the shares that is set to reach in the next 12 months. The analysts, on average, are forecasting a $3.9 price target, but the stock is already up 74.42% from its recent lows. However, the stock is trading at -78.57% versus recent highs ($8.4). Analysts believe that we could see stock price minimum in the $3.9 range (lowest target price), allowing for another 116.67% jump from its current position. Leading up to this report, we have seen a 3.45% rise in the stock price over the last 30 days and a 5.19% increase over the past 3 months. Overall, the share price is up 34.53% so far this year. Additionally, the stock had a day price range of $1.75 to $1.83.
Titan Pharmaceuticals, Inc. (TTNP) Price Potential
Heading into the stock price potential, Titan Pharmaceuticals, Inc. needs to grow just 116.67% to cross its median price target of $3.9. In order to determine directional movement, the 50-day and 200-day moving averages for Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) are $1.4707 and $0.6433. Given that liquidity is king in the short-term, TTNP is a stock with 12.9 million shares outstanding that normally trades 6.14% of its float. The stock price recently experienced a 5-day loss of 0% with 0.19 average true range (ATR). TTNP has a beta of 0.65 and RSI is 55.22.
Investors also need to beware of the Seagate Technology plc (NASDAQ:STX) valuations. The stock trades on a P/S of 0.9, which suggests that the shares are not attractive compared with peers. The broad Data Storage Devices industry has an average P/S ratio of 0.79, which is significantly better than the sector’s 2.63. In the past 13-year record, this ratio went down as low as 0.14 and as high as 1.65. Also, it is down from 56.% of the total 2318 rivals across the globe.
Seagate Technology plc (STX)’s Lead Over its Technicals
Seagate Technology plc by far traveled 35.9% versus a 1-year low price of $35.38. The share price was last seen -1.13% lower, reaching at $48.08 on Mar. 12, 2019. At recent session, the prices were hovering between $47.88 and $49.2726. This company shares are -9.9% up from its target price of $43.32 and the current market capitalization stands at $13.7B. The recent change has given its price a 11.33% lead over SMA 50 and -23.32% deficit over its 52-week high. The stock witnessed 6.8% gains, 20.5% gains and -3.45% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found STX’s volatility during a week at 3.29% and during a month it has been found around 2.36%.
Seagate Technology plc (NASDAQ:STX) Intraday Metrics
Seagate Technology plc (STX) exchanged hands at an unexpectedly high level of 3.98 million shares over the course of the day. Noting its average daily volume at 3.83 million shares each day over the month, this signifies a pretty significant change over the norm.
Seagate Technology plc Target Levels
The market experts are predicting a 31.03% rally, based on the high target price of $63 for Seagate Technology plc shares that is likely to be hit in the 52 weeks. Analysts anticipate that traders could see stock price minimum in the $32 range (lowest target price). If faced, it would be a -33.44% drop from its current position. Overall, the share price is up 24.59% year to date [T2].
This post was originally published on *this site*